Open Access
Issue
E3S Web Conf.
Volume 460, 2023
International Scientific Conference on Biotechnology and Food Technology (BFT-2023)
Article Number 11014
Number of page(s) 11
Section Functional Foods, Food and Health
DOI https://doi.org/10.1051/e3sconf/202346011014
Published online 11 December 2023
  1. M. Ajjemami, S. Ouatou, H. Charoute, M. Fakiri, H. Rhaissi, H. Benrahma, et al., Haplotype analysis of the Apolipoprotein A5 gene in Moroccan patients with the metabolic syndrome. Journal of Diabetes and Metabolic Disorders, 14 (29) (2015) https://doi.org/10.1186/s40200-015-0160-3 [CrossRef] [Google Scholar]
  2. M. Ajjemami, H. Rhaissi, H. Benrahma, H. Charoute, A. Errouagui, F. Lakbakbi, et al., Association between polymorphism in APOC3, and Metabolic Syndrome in the Moroccan Population. Int J Sci Res Publ., 4 (10) (2014) [Google Scholar]
  3. K.G.M.M. Alberti, R.H. Eckel, M. Scott, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, et al., Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120, 1640–1645 (2009) https://doi.org/10.1161/Circulationaha.109.192644 [CrossRef] [PubMed] [Google Scholar]
  4. K.G.M.M. Alberti, P. Zimmet, J. Shaw, The metabolic syndrome-A new worldwide definition. The Lancet, 366 (9491), 1059–1062 (2005) https://doi.org/10.1016/S0140-6736(05)67402-8 [CrossRef] [Google Scholar]
  5. R. Chaaba, N. Attia, S. Hammami, M. Smaoui, S. Mahjoub, M. Hammami, et al., Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetes. Lipids Health Dis., 4 (1) (2005) https://doi.org/10.1186/1476-511X-4-1. [CrossRef] [Google Scholar]
  6. S. Chadli, N. Taqarort, B. El Houate, S. Oulkheir, Epidemiological Transition in Morocco (1960-2015). Med Sante Trop. 28, 201–205 (2018) https://doi.org/10.1684/mst.2018.0800 [Google Scholar]
  7. M.M. Coates, A. Kintu, N. Gupta, E.B. Wroe, A.J. Adler, G.F. Kwan, et al., Burden of non-communicable diseases from infectious causes in 2017: A modelling study. The Lancet Global health, 8(12), e1489–e1498 (2020) https://doi.org/10.1016/S2214-109X(20)30358-2 [CrossRef] [PubMed] [Google Scholar]
  8. U. Ekelund, S. Anderssen, L.B. Anderse, C.J. Riddoch, L.B. Sardinha, J. Luan, et al., Prevalence and correlates of the metabolic syndrome in a population-based sample of European youth. The American Journal of Clinical Nutrition, 89 (1), 90–96 (2009) https://doi.org/10.3945/ajcn.2008.26649 [CrossRef] [PubMed] [Google Scholar]
  9. L.F. El Yaagoubi, H. Charoute, I. Morjane, H. Sefri, H. Rouba, A. Ainahi, et al., Association analysis of genetic variants with metabolic syndrome components in the Moroccan population. Current Research in Translational Medicine, 65 (3), 121–125 (2017) https://doi.org/10.1016/j.retram.2017.08.001 [CrossRef] [PubMed] [Google Scholar]
  10. L.E. Elkhattabi, I. Morjane, H. Charoute, A. Kettani, R. Saile, A. Barakat, Involvement of Non-synonymous Polymorphisms of the HNF1A Gene in Susceptibility to Metabolic Syndrome: Association Study and Molecular Dynamics. Atherosclerosis, 32 (54) (2018) https://doi.org/10.1016/j.atherosclerosissup.2018.04.163 [Google Scholar]
  11. G. Fahed, L. Aoun, M. Bou Zerdan, S. Allam, M. Bou Zerdan, Y. Bouferraa, et al., Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. International Journal of Molecular Sciences, 23 (2), 786 (2022) https://doi.org/10.3390/ijms23020786 [CrossRef] [PubMed] [Google Scholar]
  12. M.S. Fallah, B. Sedaghatikhayat, K. Guity, F. Akbari, F. Azizi, M.S. Daneshpour, The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level. Archives of Iranian Medicine, 19 (1), 46–50 (2016) [PubMed] [Google Scholar]
  13. B. Fathi Dizaji, The investigations of genetic determinants of the metabolic syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 12 (5), 783–789 (2018) https://doi.org/10.1016/j.dsx.2018.04.009 [CrossRef] [Google Scholar]
  14. M. Fiaz, P.A. Shaiq, G.K. Raj, M. Saqlain, A. Mehmood, S.M.S. Naqvi, et al., Association study of Apolipoprotein A5 gene (APOA5 gene) variant with the metabolic syndrome in local Pakistani population. The Journal of the Pakistan Medical Association, 69 (3), 301–305 (2019) [Google Scholar]
  15. S. Goyal, Y. Tanigawa, W. Zhang, J.F. Chai, M. Almeida, X. Sim, et al., APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups. Lipids in Health and Disease, 20 (1), 113 (2021) DOI: 10.1186/s12944-021-01531-8 [CrossRef] [PubMed] [Google Scholar]
  16. H. Grallert, E.M. Sedlmeier, C. Huth, M. Kolz, I.M. Heid, C. Meisinger, et al., APOA5 variants and metabolic syndrome in Caucasians. Journal of Lipid Research, 48 (12), 2614–2621 (2007) https://doi.org/10.1194/jlr.m700011-jlr200 [CrossRef] [PubMed] [Google Scholar]
  17. S. Grundy, Metabolic Syndrome Pandemic. Arteriosclerosis, Thrombosis, and Vascular Biology, 28 (4), 629–636 (2008) https://doi.org/10.1161/ATVBAHA.107.151092 [CrossRef] [PubMed] [Google Scholar]
  18. GWAS. Catalog metabolic syndrome EFO_0000195., in https://www.ebi.ac.uk/gwas/efotraits/EFO_0000195. Consulted août 17 (2022) [Google Scholar]
  19. M. Hechmi, H. Dallali, M. Gharbi, H. Jmel, M. Fassatoui, Y. Ben Halima, et al., Association of rs662799 variant and APOA5 gene haplotypes with metabolic syndrome and its components: A meta-analysis in North Africa. Bioscience Reports, 40 (8) (2020) BSR20200706. https://doi.org/10.1042/BSR20200706 [CrossRef] [Google Scholar]
  20. L.A. Hsu, Y.L. Ko, C.J. Chang, M.S. Teng, S. Wu, C.F. Hu, Apolipoprotein A5 gene - 1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan. Clinical Chemistry and Laboratory Medicine, 46 (12), 1714–1719 (2008) https://doi.org/10.1515/cclm.2008.352 [PubMed] [Google Scholar]
  21. J.A. Hubacek, Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants. Clinical Chemistry and Laboratory Medicine, 43 (9), 897–902 (2005) https://doi.org/10.1515/cclm.2005.153 [Google Scholar]
  22. R. Kefi, M. Hechmi, H. Dallali, H. Elouej, H. Jmel, Y. Ben Halima, et al., Association of apolipoprotein A5 gene variants with metabolic syndrome in Tunisian population. Annales d’Endocrinologie, 78 (3), 146–155 (2017) https://doi.org/10.1016/j.ando.2017.01.005. [CrossRef] [Google Scholar]
  23. Y.R. Kim, S.H. Hong. Association of Apolipoprotein A5 Gene Polymorphisms with Metabolic Syndrome in the Korean Population. Genetic Testing and Molecular Biomarkers, 20 (3), 130–136 (2016) https://doi.org/10.1089/gtmb.2015.0250 [CrossRef] [PubMed] [Google Scholar]
  24. A.T. Kraja, D. Vaidya, J.S. Pankow, M.O. Goodarzi, T.L. Assîmes, I.J. Kullo, et al., A Bivariate Genome-Wide Approach to Metabolic Syndrome: STAMPEED Consortium. Diabetes, 60 (4), 1329–1339 (2011) https://doi.org/10.2337/db10-1011 [CrossRef] [PubMed] [Google Scholar]
  25. Y. Li, C. Li, J. Gao, Apolipoprotein C3 gene variants and the risk of coronary heart disease: A meta-analysis. Meta Gene, 9, 104–109 (2016) https://doi.org/10.1016/j.mgene.2016.04.004 [CrossRef] [PubMed] [Google Scholar]
  26. A. Liberati, D.G. Altman, J. Tetzlaf, C. Mulrow, P.C. Gotzsche, J.P.A. Ioannidis, et al., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Journal of Clinical Epidemiology, 62(10), e1–e34 (2009) https://doi.org/10.1016/jjclinepi.2009.06.006 [CrossRef] [PubMed] [Google Scholar]
  27. E. Lin, P.H. Kuo, Y.L. Liu, A. Yang, S.J. Tsai, Detection of susceptibility loci on APOA5 and COLEC12 associated with metabolic syndrome using a genome-wide association study in a Taiwanese population. Oncotarget, 8 (55), 93349–93359 (2017) https://doi.org/10.18632/oncotarget.20967 [CrossRef] [PubMed] [Google Scholar]
  28. C.F. Liu, Q.F. Yang, X.L. Chen, C.Y. Liu, Apolipoprotein a5 gene polymorphism and risk for metabolic syndrome: A meta-analysis. Genetic Testing and Molecular Biomarkers, 16 (10), 1241–1245 (2012) https://doi.org/10.1089/gtmb.2012.0183 [CrossRef] [PubMed] [Google Scholar]
  29. Z.K. Liu, M. Hu, L. Baum, G.N. Thomas, B. Tomlinson, Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese. Atherosclerosis, 208 (2), 427–432 (2010) https://doi.org/10.1016/j.atherosclerosis.2009.08.013 [CrossRef] [PubMed] [Google Scholar]
  30. A. Maász, P. Kisfali, K. Horvatovich, M. Mohás, L. Markó, V. Csöngei, et al., Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome. Pathology Oncology Research, 13 (3), 243–247 (2007) https://doi.org/10.1007/bf02893505 [CrossRef] [PubMed] [Google Scholar]
  31. J. Mattei, S. Demissie, K.L. Tucker, J.M. Ordovas, Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults. The Journal of Nutrition, 139 (12), 2301–2308 (2009) https://doi.org/10.3945/jn.109.109900 [CrossRef] [PubMed] [Google Scholar]
  32. I. Morjane, R. Kefi, H. Charoute, L.F. El Yaagoubi, M. Hechmi, R. Saile, et al., Association study of HNF1A polymorphisms with metabolic syndrome in the Moroccan population. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 11(2), S853–S857 (2017) https://doi.org/10.1016/j.dsx.2017.07.005 [CrossRef] [Google Scholar]
  33. L.S. Niculescu, J. Fruchart-Najib, J.-C. Fruchart, A. Sima, Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome. Clinical Chemistry and Laboratory Medicine, 45 (9), 1133–1139 (2007) https://doi.org/10.1515/cclm.2007.257 [CrossRef] [PubMed] [Google Scholar]
  34. S.W. Oh, J.E. Lee, E. Shin, H. Kwon, E.K. Choe, S.Y. Choi, et al., Genome-wide association study of metabolic syndrome in Korean populations. PLoS One, 15(1), e0227357 (2020) https://doi.org/10.1371/journal.pone.0227357 [CrossRef] [PubMed] [Google Scholar]
  35. K.L. Ong, C.Q. Jiang, B. Liu, Y.L. Jin, A.W.K. Tso, S. Tam, et al., Association of a genetic variant in the apolipoprotein A5 gene with the metabolic syndrome in Chinese. Clinical Endocrinology, 74 (2), 206–213 (2011) https://doi.org/10.1111/j.1365-2265.2010.03899.x [CrossRef] [PubMed] [Google Scholar]
  36. S. Pekgor, C. Duran, U. Berberoglu, M.A. Eryilmaz, The Role of Visceral Adiposity Index Levels in Predicting the Presence of Metabolic Syndrome and Insulin Resistance in Overweight and Obese Patients. Metabolic Syndrome and Related Disorders, 17 (5), 296–302 (2019) https://doi.org/10.1089/met.2019.0005 [CrossRef] [PubMed] [Google Scholar]
  37. S. Pengpid, K. Peltzer, Prevalence, and correlates of the metabolic syndrome in a cross-sectional community-based sample of 18-100-year-olds in Morocco: Results of the first national STEPS survey in 2017. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14 (5), 1487–1493 (2020) https://doi.org/10.1016/j.dsx.2020.07.047 [CrossRef] [Google Scholar]
  38. L.A. Pennacchio, M. Olivier, J.A. Hubacek, J.C. Cohen, D.R. Cox, J.C. Fruchart, et al., An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science, 294 (5540), 169–173 (2001) https://doi.org/10.1126/science.1064852 [CrossRef] [PubMed] [Google Scholar]
  39. L. Qi, S. Liu, N. Rifai, D. Hunter, F.B. Hu, Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes. Atherosclerosis, 192 (1), 204–210 (2007) https://doi.org/10.1016/j.atherosclerosis.2006.05.006 [CrossRef] [PubMed] [Google Scholar]
  40. A. Rees, C.C. Shoulders, J. Stocks, D.J. Galton, F.E. Baralle, DNA polymorphism adjacent to human apoprotein A-1 gene: Relation to hypertriglyceridaemia. Lancet, 1 (8322), 444–446 (1983) https://doi.org/10.1016/s0140-6736(83)91440-x [CrossRef] [Google Scholar]
  41. M.G. Saklayen, The Global Epidemic of the Metabolic Syndrome. Current Hypertension Reports, 20 (2), 12 (2018) https://doi.org/10.1007/s11906-018-0812-z [CrossRef] [PubMed] [Google Scholar]
  42. K. Sumegi, B. Duga, B.I. Melegh, Z. Banfai, E. Kovesdi, A. Maasz, B. Melegh, Marked Differences of Haplotype Tagging SNP Distribution, Linkage, and Haplotype Profile of APOA5 Gene in Roma Population Samples. Pathology & Oncology Research, 23 (4), 853–861 (2017) https://doi.org/10.1007/s12253-017-0197-3 [CrossRef] [PubMed] [Google Scholar]
  43. P.J. Talmud, E. Hawe, S. Martin, M. Olivier, G.J. Miller, E.M. Rubin, et al., Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Human Molecular Genetics, 11 (24), 3039–3046 (2002) https://doi.org/10.1093/hmg/11.24.3039 [CrossRef] [PubMed] [Google Scholar]
  44. K.W. Van Dijk, P.C.N. Rensen, P.J. Voshol, L.M. Havekes, The role and mode of action of apolipoproteins CIII and AV: Synergistic actors in triglyceride metabolism. Current Opinion in Lipidology, 15 (3), 239–246 (2004) https://doi.org/10.1097/00041433-200406000-00002 [CrossRef] [PubMed] [Google Scholar]
  45. Y. Vasilopoulos, T. Sarafidou, V. Bagiatis, L. Skriapa, Y. Goutzelas, P. Pervanidou, et al., Association between polymorphisms in MTHFR and APOA5 and metabolic syndrome in the Greek population. Genetic Testing and Molecular Biomarkers, 15 (9), 613–617 (2011) https://doi.org/10.1089/gtmb.2010.0256 [CrossRef] [PubMed] [Google Scholar]
  46. Y. Wu, Y. Yu, T. Zhao, S. Wang, Y. Qi, et al., Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome. PLOS One, 11(1), e0147946 (2016) https://doi.org/10.1371/journal.pone.0147946 [CrossRef] [PubMed] [Google Scholar]
  47. C. Xu, R. Bai, D. Zhang, Z. Li, H. Zhu, M. Lai, et al., Effects of APOA5-1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: Evidence from a case-control study in China and a meta-analysis. PloS One, 8(2), e56216 (2013) https://doi.org/10.1371/journal.pone.0056216 [CrossRef] [PubMed] [Google Scholar]
  48. Y. Yamada, K. Kato, T. Hibino, K. Yokoi, H. Matsuo, T. Segawa, et al., Prediction of genetic risk for metabolic syndrome. Atherosclerosis, 191 (2), 298–304 (2007) https://doi.org/10.1016/j.atherosclerosis.2006.05.035 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.